114 related articles for article (PubMed ID: 32871493)
1. Preserved efficiency of sickle cell disease placentas despite altered morphology and function.
Cordier AG; Bouvier AS; Vibert F; Martinovic J; Couturier-Tarrade A; Lai-Kuen R; Curis E; Fournier T; Benachi A; Peoc'H K; Gil S
Placenta; 2020 Oct; 100():81-88. PubMed ID: 32871493
[TBL] [Abstract][Full Text] [Related]
2. Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study.
Korzeniewski SJ; Romero R; Chaiworapongsa T; Chaemsaithong P; Kim CJ; Kim YM; Kim JS; Yoon BH; Hassan SS; Yeo L
Am J Obstet Gynecol; 2016 May; 214(5):629.e1-629.e17. PubMed ID: 26688491
[TBL] [Abstract][Full Text] [Related]
3. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
Bdolah Y; Lam C; Rajakumar A; Shivalingappa V; Mutter W; Sachs BP; Lim KH; Bdolah-Abram T; Epstein FH; Karumanchi SA
Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808
[TBL] [Abstract][Full Text] [Related]
4. The prediction of fetal death with a simple maternal blood test at 20-24 weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio).
Chaiworapongsa T; Romero R; Erez O; Tarca AL; Conde-Agudelo A; Chaemsaithong P; Kim CJ; Kim YM; Kim JS; Yoon BH; Hassan SS; Yeo L; Korzeniewski SJ
Am J Obstet Gynecol; 2017 Dec; 217(6):682.e1-682.e13. PubMed ID: 29037482
[TBL] [Abstract][Full Text] [Related]
5. KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes.
Salahuddin S; Wenger JB; Zhang D; Thadhani R; Karumanchi SA; Rana S
Hypertens Pregnancy; 2016 Aug; 35(3):330-45. PubMed ID: 27028795
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
Kim MY; Buyon JP; Guerra MM; Rana S; Zhang D; Laskin CA; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Merrill JT; Stephenson MD; Gao Q; Karumanchi SA; Salmon JE
Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463
[TBL] [Abstract][Full Text] [Related]
7. Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome.
Stepan H; Hund M; Andraczek T
Hypertension; 2020 Apr; 75(4):918-926. PubMed ID: 32063058
[TBL] [Abstract][Full Text] [Related]
8. Soluble Flt1 and placental growth factor are novel determinants of newborn thyroid (dys)function: the generation R study.
Korevaar TI; Steegers EA; Schalekamp-Timmermans S; Ligthart S; de Rijke YB; Visser WE; Visser W; de Muinck Keizer-Schrama SM; Hofman A; Hooijkaas H; Bongers-Schokking JJ; Russcher H; Tiemeier H; Jaddoe VW; Visser TJ; Medici M; Peeters RP
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1627-34. PubMed ID: 24885632
[TBL] [Abstract][Full Text] [Related]
9. Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia.
Baltajian K; Hecht JL; Wenger JB; Salahuddin S; Verlohren S; Perschel FH; Zsengeller ZK; Thadhani R; Karumanchi SA; Rana S
Hypertens Pregnancy; 2014 Nov; 33(4):427-39. PubMed ID: 25062083
[TBL] [Abstract][Full Text] [Related]
10. Association of first-trimester angiogenic factors with placental histological findings in late-onset preeclampsia.
Triunfo S; Crovetto F; Crispi F; Rodriguez-Sureda V; Dominguez C; Nadal A; Peguero A; Gratacos E; Figueras F
Placenta; 2016 Jun; 42():44-50. PubMed ID: 27238713
[TBL] [Abstract][Full Text] [Related]
11. Increased placental sFlt-1 but unchanged PlGF expression in late-onset preeclampsia.
Ehrlich L; Hoeller A; Golic M; Herse F; Perschel FH; Henrich W; Dechend R; Huppertz B; Verlohren S
Hypertens Pregnancy; 2017 May; 36(2):175-185. PubMed ID: 28494189
[TBL] [Abstract][Full Text] [Related]
12. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
Govender N; Naicker T; Rajakumar A; Moodley J
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
[TBL] [Abstract][Full Text] [Related]
13. Biomarker Immunoassays in the Diagnosis of Preeclampsia: Calculating the sFlt1/PlGF Ratio Using the Cobas
Black C; da Silva Costa F
Methods Mol Biol; 2018; 1710():9-26. PubMed ID: 29196991
[TBL] [Abstract][Full Text] [Related]
14. Soluble fms-like tyrosine kinase to placental growth factor ratio in different stages of early-onset fetal growth restriction and small for gestational age.
Garcia-Manau P; Mendoza M; Bonacina E; Garrido-Gimenez C; Fernandez-Oliva A; Zanini J; Catalan M; Tur H; Serrano B; Carreras E
Acta Obstet Gynecol Scand; 2021 Jan; 100(1):119-128. PubMed ID: 32860218
[TBL] [Abstract][Full Text] [Related]
15. Gestational angiogenic biomarker patterns in high risk preeclampsia groups.
Maynard SE; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Moore Simas TA
Am J Obstet Gynecol; 2013 Jul; 209(1):53.e1-9. PubMed ID: 23517919
[TBL] [Abstract][Full Text] [Related]
16. Placental histopathology in sickle cell disease: A descriptive and hypothesis-generating study.
Malinowski AK; Dziegielewski C; Keating S; Parks T; Kingdom J; Shehata N; Rizov E; D'Souza R
Placenta; 2020 Jun; 95():9-17. PubMed ID: 32452407
[TBL] [Abstract][Full Text] [Related]
17. Circulating angiogenic factors and placental abruption.
Signore C; Mills JL; Qian C; Yu K; Lam C; Epstein FH; Karumanchi SA; Levine RJ
Obstet Gynecol; 2006 Aug; 108(2):338-44. PubMed ID: 16880304
[TBL] [Abstract][Full Text] [Related]
18. Abnormal expression of inflammatory genes in placentas of women with sickle cell anemia and sickle hemoglobin C disease.
Baptista LC; Costa ML; Ferreira R; Albuquerque DM; Lanaro C; Fertrin KY; Surita FG; Parpinelli MA; Costa FF; Melo MB
Ann Hematol; 2016 Oct; 95(11):1859-67. PubMed ID: 27546026
[TBL] [Abstract][Full Text] [Related]
19. Placenta growth factor activates monocytes and correlates with sickle cell disease severity.
Perelman N; Selvaraj SK; Batra S; Luck LR; Erdreich-Epstein A; Coates TD; Kalra VK; Malik P
Blood; 2003 Aug; 102(4):1506-14. PubMed ID: 12714517
[TBL] [Abstract][Full Text] [Related]
20. A longitudinal study of plasma levels of soluble fms-like tyrosine kinase 1 (sFlt1), placental growth factor (PlGF), sFlt1: PlGF ratio and vascular endothelial growth factor (VEGF-A) in normal pregnancy.
Palm M; Basu S; Larsson A; Wernroth L; Åkerud H; Axelsson O
Acta Obstet Gynecol Scand; 2011 Nov; 90(11):1244-51. PubMed ID: 21568945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
